Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
International Journal of Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Chrostowski, P. C.
Right arrow Articles by Estreicher, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Chrostowski, P. C.
Right arrow Articles by Estreicher, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Endocrine-Modulating Chemicals as a Case Study of Science in the Courtroom

Paul C. Chrostowski

CPF Associates, Inc., Takoma Park, MD, USA

Judi L. Durda

The Weinberg Group Inc., Washington, D.C., USA

Herbert Estreicher

Covington & Burling, Washington, D.C., USA

In contemporary society, many scientific issues involving toxi-cologists, epidemiologists, and other risk assessment professionals have become the topics of hotly contested legal actions. Nowhere is this more apparent than in toxic tort cases where judgements involving millions of dollars can hinge on the expert testimony provided by a toxicologist. Many of these cases involve scientific opinions that have not yet entered the mainstream of scientific thought, thus it becomes necessary for courts to place a great deal of emphasis on the reliability of science. In this paper, we analyze the scientific and legal bases of disease causation in the toxic tort context and illustrate how the emerging issue of endocrine modulation may evolve in this context. We conclude that there is an inadequate scientific basis to show personal injuries associated with exposure to a class of putative endocrine modulators. This paper is not intended to illustrate a specific case; it is intended to be a heuristic for toxicologists, risk assessors, and attorneys, who may be forced to confront these and similar issues in the course of their professional careers.

Key Words: Endocrine Modulators • Phthalates • Expert Testimony • Daubert

International Journal of Toxicology, Vol. 18, No. 3, 201-207 (1999)
DOI: 10.1080/109158199225503


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
International Journal of ToxicologyHome page
S. J. Northup
Toxicity, Risk Assessment, and the Law--Introductory Remarks
International Journal of Toxicology, April 1, 1999; 18(3): 199 - 200.
[PDF]